Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Abschlussarbeit Buch |
Sprache: | English |
Veröffentlicht: |
Hamburg
2021
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis Inhaltsverzeichnis |
Beschreibung: | 74 Blätter Illustrationen, Diagramme 30 cm |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV048929784 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 230505s2021 gw a||| m||| 00||| eng d | ||
015 | |a 22,H12 |2 dnb | ||
016 | 7 | |a 1270544837 |2 DE-101 | |
020 | |c Broschur | ||
035 | |a (OCoLC)1353600489 | ||
035 | |a (DE-599)DNB1270544837 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE | ||
049 | |a DE-355 | ||
084 | |8 2\p |a 610 |2 23sdnb | ||
084 | |a 610 |2 sdnb | ||
084 | |8 1\p |a 616.994 |2 23ksdnb | ||
084 | |8 3\p |a 570 |2 23sdnb | ||
100 | 1 | |a Marquard, Franziska Elisabeth |e Verfasser |0 (DE-588)1271192772 |4 aut | |
245 | 1 | 0 | |a Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer |c vorgelegt von: Franziska Elisabeth Marquaed |
264 | 1 | |a Hamburg |c 2021 | |
300 | |a 74 Blätter |b Illustrationen, Diagramme |c 30 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
502 | |b Dissertation |c Universität Hamburg |d 2022 | ||
655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
856 | 4 | 2 | |m B:DE-101 |q application/pdf |u https://d-nb.info/1270544837/04 |3 Inhaltsverzeichnis |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034193752&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-034193752 | ||
883 | 0 | |8 1\p |a emakn |c 0,33542 |d 20221026 |q DE-101 |u https://d-nb.info/provenance/plan#emakn | |
883 | 2 | |8 2\p |a dnb |d 20221110 |q DE-101 |u https://d-nb.info/provenance/plan#dnb | |
883 | 2 | |8 3\p |a dnb |d 20221110 |q DE-101 |u https://d-nb.info/provenance/plan#dnb |
Datensatz im Suchindex
_version_ | 1804185119154503680 |
---|---|
adam_text | 1.
WORK
HYPOTHESIS
AND
QUESTIONING
..................................
6
2.
INTRODUCTION
.......................................................................
6
2.1
HEAD
AND
NECK
CANCER
...............................................................................................................
6
2.1.2
EPIDEMIOLOGY
AND
CHARACTERISTICS
.........................................................................................
6
2.1.3
CURRENT
THERAPY
......................................................................................................................
8
2.2
PI3K/AKT/MTOR
SIGNALING
........................................................................................................
10
2.2.1
THE
PATHWAY
........................................................................................................................
10
2.2.2
AKT
AND
ITS
ISOFORMS
............................................................................................................
11
2.2.3
MTOR
...................................................................................................................................
11
2.3
GENETIC
ALTERATIONS
IN
PI3K/AKT/MTOR
SIGNALING
FOUND
IN
HEAD
AND
NECK
CANCER
.........
12
2.4
AKT
AND
MTOR
INHIBITORS
IN
HEAD
AND
NECK
CANCER
.............................................................
13
2.4.1
AKT
INHIBITORS
.......................................................................................................................
13
2.4.2 MTOR
INHIBITORS
...................................................................................................................
14
2.4.3
COMBINED
THERAPY
................................................................................................................
15
3.
MATERIALS
AND
METHODS
...................................................
16
3.1
MATERIALS
....................................................................................................................................
16
3.1.1
MACHINES
AND
DEVICES
.........................................................................................................
16
3.1.3
BUFFER
AND
SOLUTIONS
.............................................................................................................
18
3.1.4
KITS
AND
MARKER
...................................................................................................................
21
3.1.5
ANTIBODIES
............................................................................................................................
21
3.1.7
VECTORS
................................................................................................................................
22
3.1.8
INHIBITORS
..............................................................................................................................22
3.2
CELL
LINES
.................................................................................................................................
23
3.3
SOFTWARE
.....................................................................................................................................
23
3.4
CELL
CULTURE
................................................................................................................................
23
3.4.1
DEFROSTING
CELLS
....................................................................................................................
24
3.4.2
PASSAGING
............................................................................................................................
24
3.4.3
FREEZING
CELLS
......................................................................................................................
24
3.4.3
EVALUATING
CELL
CONCENTRATIONS
.............................................................................................
24
3.5
INCUCYTE
ASSAYS
.......................................................................................................................
24
3.5.1
PROLIFERATION
.........................................................................................................................
24
3.5.2
SCRATCH
ASSAY
.....................................................................................................................
25
3.6
ALAMAR
BLUE
VIABILITY
ASSAY
.....................................................................................................
25
3
3.7
CELL
PROLIFERATION
ANALYSIS
VIA
CELL
COUNTING
...........................................................................
25
3.8
ANALYSIS
OF
APOPTOSIS
THROUGH
FLUORESCENCE
ACTIVATED
CELL
SCANNING
(FACS)
..................
25
3.9
LENTIVIRAL
KNOCKDOWN
OF
AKT
ISOFORMS
.................................................................................
26
2.9.1
TRANSFORMATION
.....................................................................................................................
26
3.9.2
PLASMID
PREPARATION
.............................................................................................................
26
3.9.3
TRANSFECTION
OFHEK293T
....................................................................................................
27
3.9.4
TRANSDUCTION
.........................................................................................................................
27
3.7
WESTERN
BLOT
.............................................................................................................................
27
3.7.1
PRODUCTION
OF
PROTEIN
LYSATES
USING
NP40
LYSIS
BUFFER
.........................................................27
3.7.2 DETERMINATION
OFTHE
PROTEIN
CONCENTRATION
USING
THE
DC
PROTEIN
ASSAY
KIT
.........................
28
3.7.3
SDS-PAGE
.............................................................................................................................
28
3.7.4
TRANSFER
AND
DEVELOPMENT
..................................................................................................
29
2.6
STATISTICAL
ANALYSIS
...................................................................................................................
29
4.
RESU
ITS
.............................................................................
30
4.1
AKT
AND
MTOR
ACTIVITY
IN
DIFFERENT
HNSCC
CELL
LINES
..........................................................
30
4.2
KNOCK
DOWN
OF
AKT
ISOFORMS
IN
UT-SCC
24A
AND
UT-SCC
24B
.........................................
30
4.2.1
EFFECT
OFAKT
ISOFORM
KNOCK
DOWN
ON
PROTEIN
EXPRESSION
AND
SIGNALING
.............................
30
4.2.2
PROLIFERATION
.........................................................................................................................
36
4.2.3
VIABILITY
................................................................................................................................
38
4.2.4
APOPTOSIS
.............................................................................................................................40
4.2.5
MIGRATION
..............................................................................................................................40
4.3
AKT
AND
MTOR
INHIBITORS
IN
UT-SCC
24A
AND
UT-SCC
24B
...............................................
41
4.3.1
PROLIFERATION
.........................................................................................................................
41
4.3.2
MIGRATION
..............................................................................................................................
44
4.3.3
PROTEIN
EXPRESSION
AND
SIGNALING
........................................................................................
47
5.
DISCUSSION
.......................................................................
50
6.
SUMMARY
..........................................................................
59
6.1
ENGLISH
.......................................................................................................................................
59
6.2
GERMAN
......................................................................................................................................
60
7.
ABBREVIATIONS
..................................................................
61
4
8.
REFERENCES
.......................................................................
62
9.
DANKSAGUNG
.....................................................................
72
10.
LEBENSLAUF
.....................................................................
72
11.
EIDESSTATTLICHE
VERSICHERUNG
.......................................
74
5
|
adam_txt |
1.
WORK
HYPOTHESIS
AND
QUESTIONING
.
6
2.
INTRODUCTION
.
6
2.1
HEAD
AND
NECK
CANCER
.
6
2.1.2
EPIDEMIOLOGY
AND
CHARACTERISTICS
.
6
2.1.3
CURRENT
THERAPY
.
8
2.2
PI3K/AKT/MTOR
SIGNALING
.
10
2.2.1
THE
PATHWAY
.
10
2.2.2
AKT
AND
ITS
ISOFORMS
.
11
2.2.3
MTOR
.
11
2.3
GENETIC
ALTERATIONS
IN
PI3K/AKT/MTOR
SIGNALING
FOUND
IN
HEAD
AND
NECK
CANCER
.
12
2.4
AKT
AND
MTOR
INHIBITORS
IN
HEAD
AND
NECK
CANCER
.
13
2.4.1
AKT
INHIBITORS
.
13
2.4.2 MTOR
INHIBITORS
.
14
2.4.3
COMBINED
THERAPY
.
15
3.
MATERIALS
AND
METHODS
.
16
3.1
MATERIALS
.
16
3.1.1
MACHINES
AND
DEVICES
.
16
3.1.3
BUFFER
AND
SOLUTIONS
.
18
3.1.4
KITS
AND
MARKER
.
21
3.1.5
ANTIBODIES
.
21
3.1.7
VECTORS
.
22
3.1.8
INHIBITORS
.22
3.2
CELL
LINES
.
23
3.3
SOFTWARE
.
23
3.4
CELL
CULTURE
.
23
3.4.1
DEFROSTING
CELLS
.
24
3.4.2
PASSAGING
.
24
3.4.3
FREEZING
CELLS
.
24
3.4.3
EVALUATING
CELL
CONCENTRATIONS
.
24
3.5
INCUCYTE
ASSAYS
.
24
3.5.1
PROLIFERATION
.
24
3.5.2
SCRATCH
ASSAY
.
25
3.6
ALAMAR
BLUE
VIABILITY
ASSAY
.
25
3
3.7
CELL
PROLIFERATION
ANALYSIS
VIA
CELL
COUNTING
.
25
3.8
ANALYSIS
OF
APOPTOSIS
THROUGH
FLUORESCENCE
ACTIVATED
CELL
SCANNING
(FACS)
.
25
3.9
LENTIVIRAL
KNOCKDOWN
OF
AKT
ISOFORMS
.
26
2.9.1
TRANSFORMATION
.
26
3.9.2
PLASMID
PREPARATION
.
26
3.9.3
TRANSFECTION
OFHEK293T
.
27
3.9.4
TRANSDUCTION
.
27
3.7
WESTERN
BLOT
.
27
3.7.1
PRODUCTION
OF
PROTEIN
LYSATES
USING
NP40
LYSIS
BUFFER
.27
3.7.2 DETERMINATION
OFTHE
PROTEIN
CONCENTRATION
USING
THE
DC
PROTEIN
ASSAY
KIT
.
28
3.7.3
SDS-PAGE
.
28
3.7.4
TRANSFER
AND
DEVELOPMENT
.
29
2.6
STATISTICAL
ANALYSIS
.
29
4.
RESU
ITS
.
30
4.1
AKT
AND
MTOR
ACTIVITY
IN
DIFFERENT
HNSCC
CELL
LINES
.
30
4.2
KNOCK
DOWN
OF
AKT
ISOFORMS
IN
UT-SCC
24A
AND
UT-SCC
24B
.
30
4.2.1
EFFECT
OFAKT
ISOFORM
KNOCK
DOWN
ON
PROTEIN
EXPRESSION
AND
SIGNALING
.
30
4.2.2
PROLIFERATION
.
36
4.2.3
VIABILITY
.
38
4.2.4
APOPTOSIS
.40
4.2.5
MIGRATION
.40
4.3
AKT
AND
MTOR
INHIBITORS
IN
UT-SCC
24A
AND
UT-SCC
24B
.
41
4.3.1
PROLIFERATION
.
41
4.3.2
MIGRATION
.
44
4.3.3
PROTEIN
EXPRESSION
AND
SIGNALING
.
47
5.
DISCUSSION
.
50
6.
SUMMARY
.
59
6.1
ENGLISH
.
59
6.2
GERMAN
.
60
7.
ABBREVIATIONS
.
61
4
8.
REFERENCES
.
62
9.
DANKSAGUNG
.
72
10.
LEBENSLAUF
.
72
11.
EIDESSTATTLICHE
VERSICHERUNG
.
74
5 |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
author | Marquard, Franziska Elisabeth |
author_GND | (DE-588)1271192772 |
author_facet | Marquard, Franziska Elisabeth |
author_role | aut |
author_sort | Marquard, Franziska Elisabeth |
author_variant | f e m fe fem |
building | Verbundindex |
bvnumber | BV048929784 |
ctrlnum | (OCoLC)1353600489 (DE-599)DNB1270544837 |
discipline | Medizin |
discipline_str_mv | Medizin |
format | Thesis Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01747nam a2200421 c 4500</leader><controlfield tag="001">BV048929784</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">230505s2021 gw a||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">22,H12</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1270544837</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="c">Broschur</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1353600489</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1270544837</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">3\p</subfield><subfield code="a">570</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Marquard, Franziska Elisabeth</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1271192772</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer</subfield><subfield code="c">vorgelegt von: Franziska Elisabeth Marquaed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hamburg</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">74 Blätter</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">30 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Universität Hamburg</subfield><subfield code="d">2022</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">https://d-nb.info/1270544837/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034193752&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034193752</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">emakn</subfield><subfield code="c">0,33542</subfield><subfield code="d">20221026</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emakn</subfield></datafield><datafield tag="883" ind1="2" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">dnb</subfield><subfield code="d">20221110</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#dnb</subfield></datafield><datafield tag="883" ind1="2" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">dnb</subfield><subfield code="d">20221110</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#dnb</subfield></datafield></record></collection> |
genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
genre_facet | Hochschulschrift |
id | DE-604.BV048929784 |
illustrated | Illustrated |
index_date | 2024-07-03T21:56:58Z |
indexdate | 2024-07-10T09:50:10Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034193752 |
oclc_num | 1353600489 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 74 Blätter Illustrationen, Diagramme 30 cm |
publishDate | 2021 |
publishDateSearch | 2021 |
publishDateSort | 2021 |
record_format | marc |
spelling | Marquard, Franziska Elisabeth Verfasser (DE-588)1271192772 aut Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer vorgelegt von: Franziska Elisabeth Marquaed Hamburg 2021 74 Blätter Illustrationen, Diagramme 30 cm txt rdacontent n rdamedia nc rdacarrier Dissertation Universität Hamburg 2022 (DE-588)4113937-9 Hochschulschrift gnd-content B:DE-101 application/pdf https://d-nb.info/1270544837/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034193752&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p emakn 0,33542 20221026 DE-101 https://d-nb.info/provenance/plan#emakn 2\p dnb 20221110 DE-101 https://d-nb.info/provenance/plan#dnb 3\p dnb 20221110 DE-101 https://d-nb.info/provenance/plan#dnb |
spellingShingle | Marquard, Franziska Elisabeth Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer |
subject_GND | (DE-588)4113937-9 |
title | Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer |
title_auth | Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer |
title_exact_search | Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer |
title_exact_search_txtP | Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer |
title_full | Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer vorgelegt von: Franziska Elisabeth Marquaed |
title_fullStr | Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer vorgelegt von: Franziska Elisabeth Marquaed |
title_full_unstemmed | Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer vorgelegt von: Franziska Elisabeth Marquaed |
title_short | Investigations of PI3K/AKT/mTOR signaling and its functional role in head and neck cancer |
title_sort | investigations of pi3k akt mtor signaling and its functional role in head and neck cancer |
topic_facet | Hochschulschrift |
url | https://d-nb.info/1270544837/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034193752&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT marquardfranziskaelisabeth investigationsofpi3kaktmtorsignalinganditsfunctionalroleinheadandneckcancer |
Es ist kein Print-Exemplar vorhanden.
Inhaltsverzeichnis